Peter Staple
Chairman chez ASSERTIO HOLDINGS, INC.
Fortune : 268 996 $ au 31/03/2024
Profil
Peter D.
Staple's current jobs include being the Independent Chairman at Assertio Holdings, Inc. since 2020, the Director at Kyto Technology & Life Science, Inc. since 2021, the Director at Corsair Pharma, Inc. since 2020, and the Trustee at The Campaign Legal Center since 2020.
His former jobs include being the Chairman at Assertio Therapeutics, Inc. from 2009 to 2017, the Chairman at Corium International, Inc. from 2019 to 2020, a Director at Lygos, Inc. from 2002 to 2008, a Director at BioSeek, Inc. from 2007 to 2008, the Chief Administrative Officer & General Counsel at ALZA Corp.
from 1994 to 2002, the Vice President & Associate General Counsel at Chiron Corp.
from 1991 to 1994, and the Vice President & Associate General Counsel at Cetus Corp.
from 1983 to 1991.
Mr. Staple's education includes an undergraduate degree from Stanford University in 1974 and a graduate degree from Stanford Law School in 1981.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
ASSERTIO HOLDINGS, INC.
0,30% | 13/06/2023 | 280 496 ( 0,30% ) | 268 996 $ | 31/03/2024 |
Postes actifs de Peter Staple
| Sociétés | Poste | Début |
|---|---|---|
| ASSERTIO HOLDINGS, INC. | Chairman | 30/12/2020 |
| K2X TECHNOLOGY & LIFE SCIENCE, INC. | Director/Board Member | 08/01/2021 |
The Campaign Legal Center
 The Campaign Legal Center Miscellaneous Commercial ServicesCommercial Services The Campaign Legal Center operates as a nonprofit organization that represents the public interest in reducing the influence of money in the political system, strengthening voting rights, and regulating lobbying. The company was founded by Trevor Potter in 2002 and is headquartered in Washington, DC. | Director/Board Member | 01/05/2020 |
Corsair Pharma, Inc.
 Corsair Pharma, Inc. BiotechnologyHealth Technology Corsair Pharma, Inc. is a development stage biotechnology company. It focuses on the development of novel prodrugs of treprostinil to treat patients with pulmonary arterial hypertension using a once-daily transdermal patch. The company is headquartered in South San Francisco, CA. | Director/Board Member | 01/12/2020 |
Anciens postes connus de Peter Staple
| Sociétés | Poste | Fin |
|---|---|---|
| CORIUM INTERNATIONAL INC | Chief Executive Officer | 02/04/2019 |
BioSeek, Inc.
 BioSeek, Inc. Miscellaneous Commercial ServicesCommercial Services BioSeek, an Asterand company, is improving the success rate of pharmaceutical research and development by integrating human biology from the earliest stages of drug discovery onward. Their BioMAP® Systems incorporate predictive primary human cell-based disease models that generate uniquely informative biological activity profiles for each potential drug. As a result, their technology drives the selection and development of new drug candidates. they leverage their BioMAP® Systems technology in collaborations to enhance the productivity of their pharmaceutical partners' pipelines to identify promising compounds for therapeutic development. Asterand plc acquired BioSeek on February 18, 2010. Asterand is the leading global supplier of high quality, well characterized human tissue and human tissue-based research services to drug discovery scientists. BioSeek's BioMAP® platform and primary human cell based assays are highly complementary to the human tissue-based products and services offered by Asterand. Formed in January 2006 from the merger of Asterand, a human tissue biorepository, and Pharmagene, a human tissue-based drug discovery company, Asterand plc is uniquely positioned to provide a comprehensive approach to meet the research needs of pharmaceutical and biotechnology companies. From their offices in Royston (United Kingdom), San Francisco, California and Detroit, Michigan they have more than 90 employees focused on providing services and products to accelerate drug discovery research from target identification through to compound evaluation and drug safety. | Chief Executive Officer | 01/11/2007 |
Lygos, Inc.
 Lygos, Inc. Chemicals: Major DiversifiedProcess Industries Lygos, Inc. engages in the development of full-stack biological engineering platform. Its platform focuses on organic acid specialty chemicals and bio-monomers. The company was founded by Eric Steen, Jeffrey Dietrich, Jay D. Keasling, Leonard Katz, and J. L. Clem Fortman in 2010 and is headquartered in Berkeley, CA. | Director/Board Member | 01/01/2008 |
| ALZA CORPORATION | Chief Administrative Officer | 01/01/2002 |
Chiron Corp.
 Chiron Corp. Medical SpecialtiesHealth Technology Chiron Corp. provides nucleic acid test for blood screening. Its products include tigris system, target capture system, reagent preparation incubator, and many more. The company was founded in 1981 by William J. Rutter, Edward E. Penhoet & Pablo Valenzuela and is headquartered in Emeryville, CA. | Corporate Officer/Principal | 01/01/1994 |
Formation de Peter Staple
| Stanford University | Undergraduate Degree |
| Stanford Law School | Graduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 2 |
|---|---|
| K2X TECHNOLOGY & LIFE SCIENCE, INC. | Health Technology |
| ASSERTIO HOLDINGS, INC. | Health Technology |
| Entreprise privées | 9 |
|---|---|
ALZA Corp.
 ALZA Corp. Pharmaceuticals: MajorHealth Technology ALZA Corp. provides drug delivery solutions and develops pharmaceutical products. The company applies its delivery technologies to develop pharmaceutical products with enhanced therapeutic value for its own portfolio and for many of the world's leading pharmaceutical companies. The company was founded by Martin Gerstel and Alejandro Zaffaroni in 1968 and is headquartered in Vacaville, CA. | Health Technology |
Chiron Corp.
Chiron Corp. Medical SpecialtiesHealth Technology Chiron Corp. provides nucleic acid test for blood screening. Its products include tigris system, target capture system, reagent preparation incubator, and many more. The company was founded in 1981 by William J. Rutter, Edward E. Penhoet & Pablo Valenzuela and is headquartered in Emeryville, CA. | Health Technology |
Assertio Therapeutics, Inc.
 Assertio Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Assertio Therapeutics, Inc. engages in the manufacture and distribution of pharmaceutical products to treat pain and other central nervous system conditions. Its brands include Gralise, Zipsor, Lazanda, Cambia, NUCYNTA ER and NUCYNTA. The firm focuses on neurology, orphan and specialty medicines. The company was founded by John W. Shell on August 7, 1995 and is headquartered in Lake Forest, IL. | Health Technology |
Lygos, Inc.
Lygos, Inc. Chemicals: Major DiversifiedProcess Industries Lygos, Inc. engages in the development of full-stack biological engineering platform. Its platform focuses on organic acid specialty chemicals and bio-monomers. The company was founded by Eric Steen, Jeffrey Dietrich, Jay D. Keasling, Leonard Katz, and J. L. Clem Fortman in 2010 and is headquartered in Berkeley, CA. | Process Industries |
| Cetus Corp. | Health Technology |
BioSeek, Inc.
BioSeek, Inc. Miscellaneous Commercial ServicesCommercial Services BioSeek, an Asterand company, is improving the success rate of pharmaceutical research and development by integrating human biology from the earliest stages of drug discovery onward. Their BioMAP® Systems incorporate predictive primary human cell-based disease models that generate uniquely informative biological activity profiles for each potential drug. As a result, their technology drives the selection and development of new drug candidates. they leverage their BioMAP® Systems technology in collaborations to enhance the productivity of their pharmaceutical partners' pipelines to identify promising compounds for therapeutic development. Asterand plc acquired BioSeek on February 18, 2010. Asterand is the leading global supplier of high quality, well characterized human tissue and human tissue-based research services to drug discovery scientists. BioSeek's BioMAP® platform and primary human cell based assays are highly complementary to the human tissue-based products and services offered by Asterand. Formed in January 2006 from the merger of Asterand, a human tissue biorepository, and Pharmagene, a human tissue-based drug discovery company, Asterand plc is uniquely positioned to provide a comprehensive approach to meet the research needs of pharmaceutical and biotechnology companies. From their offices in Royston (United Kingdom), San Francisco, California and Detroit, Michigan they have more than 90 employees focused on providing services and products to accelerate drug discovery research from target identification through to compound evaluation and drug safety. | Commercial Services |
Corium International, Inc.
 Corium International, Inc. Pharmaceuticals: MajorHealth Technology Corium International, Inc. is a pharmaceutical company. It offers products such as corplex donepezil and memantine. The company was founded by Gary W. Cleary and Adrian L. Faasse, Jr. in 1999 and is headquartered in Menlo Park, CA. | Health Technology |
The Campaign Legal Center
The Campaign Legal Center Miscellaneous Commercial ServicesCommercial Services The Campaign Legal Center operates as a nonprofit organization that represents the public interest in reducing the influence of money in the political system, strengthening voting rights, and regulating lobbying. The company was founded by Trevor Potter in 2002 and is headquartered in Washington, DC. | Commercial Services |
Corsair Pharma, Inc.
Corsair Pharma, Inc. BiotechnologyHealth Technology Corsair Pharma, Inc. is a development stage biotechnology company. It focuses on the development of novel prodrugs of treprostinil to treat patients with pulmonary arterial hypertension using a once-daily transdermal patch. The company is headquartered in South San Francisco, CA. | Health Technology |
